
Daily Science Podcast dari Michael Bruckman
Michael Bruckman
Kategori: Sains & Kedokteran
Dengarkan episode terakhir:
d-mannose induces regulatory T cells and suppresses immunopathology
by WanJun Chen from the Mucosal Immunology Section of NIH
Funded by NIH
Abstract: d-mannose, a C-2 epimer of glucose, exists naturally in many plants and fruits, and is found in human blood at concentrations less than one-fiftieth of that of glucose. However, although the roles of glucose in T cell metabolism, diabetes and obesity are well characterized, the function of d-mannose in T cell immune responses remains unknown. Here we show that supraphysiological levels of d-mannose safely achievable by drinking-water supplementation suppressed immunopathology in mouse models of autoimmune diabetes and airway inflammation, and increased the proportion of Foxp3+ regulatory T cells (Treg cells) in mice. In vitro, d-mannose stimulated Treg cell differentiation in human and mouse cells by promoting TGF-b activation, which in turn was mediated by upregulation of integrin avb8 and reactive oxygen species generated by increased fatty acid oxidation. This previously unrecognized immunoregulatory function of d-mannose may have clinical applications for immunopathology.
Notes:
- Fruits containing Mannose: cranberries, tomatoes, apples, peaches, and blueberries
- Vegetables containing mannose: green beans, cabbage, broccoli, and eggplant
- “d-mannose is a C-2 epimer of glucose and occurs naturally in many plants and fruits, especially cranberries.”
- “For example, a d-mannose supplement has been shown to be an effective therapy for congenital disorders of glycosylation type Ib2,4. It has also been used as a non-antibiotic treatment for bacterial urinary tract infection in animals5 and humans6, with a proposed mechanism of binding to the type 1 pili of enteric bacteria and thereby blocking their adhesion to uroepithelial cells7.”
- “However, it is unknown whether d-mannose has any effect on T cells and immune responses. Here we show that oral administration of d-mannose suppressed immunopathology in models of autoimmune diabetes and airway inflammation.”
- “We administered d-mannose in drinking water to BALB/cJ mice for 2 weeks,”
- “hus, as in mouse T cells, d-mannose also drove Treg cell generation in human naive CD4+ T cells via a TGF-β-dependent mechanism.”
- “TGF-β is produced as a latent form in complex with latent associated protein (LAP)28,29”
- “We next determined whether d-mannose has beneficial effects in autoimmunity, using as a type 1 diabetes model non-obese diabetic (NOD) mice, in which pathology involves Treg cell defects40. NOD mice received d-mannose in their drinking water starting at 7.5 weeks of age, when the mice are considered prediabetic, and at which point the inflammatory process has just been initiated but blood glucose levels are still within the normal range40 (Supplementary Fig. 11a). As expected, control (non-d-mannose-treated) NOD mice started to develop diabetes at about 12–13 weeks of age, and 80–90% became diabetic by the age of 23 weeks (Fig. 4a). However, most of the NOD mice supplemented with d-mannose were diabetes-free through 23 weeks of age (Fig. 4a).”
- “Moreover, treatment of NOD mice with d-mannose once they had reached prediabetic blood glucose levels of 140–160 mg/dL (Supplementary Fig. 11e) or new-onset diabetic levels of 200–230 mg/dL (refs. 41,42) (Supplementary Fig. 12a) suppressed the progression of diabetes (Fig. 4h–k, Supplementary Fig. 12b–d).”
- “We next tested d-mannose function in a model of lung airway inflammation.”
- “Indeed, we found that d-mannose treatment prevented the development of airway inflammation in the lungs, as demonstrated by considerably less infiltration of inflammatory cells and reduced mucus production in the airways compared with that in control mice (Fig. 6a,b).”
- “To investigate whether d-mannose can be effective in a clinically relevant setting, we first induced airway inflammation in the mice and then treated them with d-mannose in drinking water (Supplementary Fig. 15a). We found that d-mannose treatment significantly ameliorated airway inflammation (Fig. 6g–i).”
- “Here we have outlined a previously unrecognized ability of d-mannose, a hexose sugar, to suppress experimental type 1 diabetes and lung airway inflammation.”
- “Of note, long-term supplementation with d-mannose had no obvious side-effects in the NOD mice—a finding that might have implications for the development of a similar clinical therapy for type 1 diabetes in humans49.”
- “However, it should be noted that the reasons for the lack of an increased frequency of Treg cells among the polyclonal nontransgenic CD4+ T cells remain unknown and require further investigation.”
- “A previous study showed that a high concentration of glucose (for example, >25 mM) can activate TGF-β and may be involved in the growth of epithelial and mesenchymal cells46.”
- “Notably, we replicated and confirmed this immunoregulatory effect of d-mannose in an ovalbumin-induced airway inflammation model, which indicates broader efficacy of mannose-mediated therapeutic effects on immunopathology.”
- “The physiological level of d-mannose in the blood of humans and mice is approximately 100 μM. However, it has been reported that the amount of circulating d-mannose increases up to ninefold (from 100 to 900 μM) in mice receiving d-mannose in drinking water, with no adverse consequences49.”
- “In humans, stable serum d-mannose levels of up to 2 mM can be reached and are well tolerated, without signs of liver or renal toxicity51.”
- “Moreover, the possible connection between the consumption of fruits rich in d-mannose (for example, cranberries) and autoimmunity may be an interesting and important issue.”
Episode sebelumnya
-
37 - Mannose suppresses immunopathology; preventing diabetes and airway inflammation Thu, 21 Sep 2017
-
36 - Quality Control in Academic Labs Sun, 10 Sep 2017
-
35 - September 6, 2017 - The Future of Alzheimer's Disease Treatment Wed, 06 Sep 2017
-
34 - August 31, 2017 - Gut bacteria protecting cancer Fri, 01 Sep 2017
-
33 - August 29, 2017 - Energy harvesting yarn Tue, 29 Aug 2017
-
32 - August 26, 2017 - Science Advocacy is for Everyone Sat, 26 Aug 2017
-
31 - August 23, 2017 - A mechanism to reverse rheumatoid arthritis Wed, 23 Aug 2017
-
30 - August 21, 2017 - A new cancer immunotherapy nanoparticle Mon, 21 Aug 2017
-
29 - August 19, 2017 - Depression in Science Sat, 19 Aug 2017
-
28 - August 16, 2017 - Nanoparticle immune activation to treat leukemia Wed, 16 Aug 2017
-
27 - August 14, 2017 - New biomimetic bandages Mon, 14 Aug 2017
-
26 - August 13, 2017 - How to establish academic technology transfer Sun, 13 Aug 2017
-
25 - August 11, 2017 - Funding Agency Peer Reviewer Fatigue Fri, 11 Aug 2017
-
24 - August 10, 2017 - A longitudinal wellness study using full body scans Thu, 10 Aug 2017
-
23 - August 9, 2017 - New Thin Film Manufacturing Wed, 09 Aug 2017
-
22 - August 8, 2017 - Preventing and understanding chronic pain Tue, 08 Aug 2017
-
21 - August 7, 2017 - Summary of July, 2017 Podcasts Mon, 07 Aug 2017
-
20 - August 4, 2017 - Gender Bias in Science Fri, 04 Aug 2017
-
19 - August 3, 2017 - In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target Thu, 03 Aug 2017
-
18 - August 1, 2017 - Regulation of body weight and energy homeostasis by neuronal cell adhesion molecule 1 Tue, 01 Aug 2017
-
17 - July 28, 2017 - Promote scientific integrity via journal peer review data Fri, 28 Jul 2017
-
16 - July 27, 2017 - Highly elastic binders integrating polyrotaxanes for silicon microparticle anodes in lithium ion batteries Fri, 28 Jul 2017
-
15 - July 26, 2017 - CRISPR–Cas encoding of a digital movie into the genomes of a population of living bacteria Wed, 26 Jul 2017
-
14 - July 25, 2017 - Designer vaccine nanodiscs for personalized cancer immunotherapy Wed, 26 Jul 2017
-
13 - July 17, 2017 - Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation Mon, 17 Jul 2017
-
12 - July 21, 2017 - Weekly Policy and Politics in Science Episode Fri, 21 Jul 2017
-
11 - July 20, 2017 - Cortex-dependent recovery of unassisted hindlimb locomotion after complete spinal cord injury in adult rats Thu, 20 Jul 2017
-
10 - July 19, 2017 - Global analysis of protein folding using massively parallel design, synthesis, and testing Wed, 19 Jul 2017
-
9 - 3D Printed Stretchable Tactile Sensors Tue, 18 Jul 2017
-
8 - July 14, 2017 - Trump’s science shop is small and waiting for leadership Fri, 14 Jul 2017
-
7 - July 13, 2017 - Fine-mapping inflammatory bowel disease loci to single-variant resolution Thu, 13 Jul 2017
-
6 - July 12, 2017 - Decreased alertness due to sleep loss increases pain sensitivity in mice Wed, 12 Jul 2017
-
5 - July 11, 2017 Thalamic projections sustain prefrontal activity during working memory maintenance Tue, 11 Jul 2017
-
4 - July 10, 2017 - Three-dimensional integration of nanotechnologies for computing and data storage on a single chip Mon, 10 Jul 2017
-
3 - July 7, 2017 - Liquefied gas electrolytes for electrochemical energy storage devices Fri, 07 Jul 2017
-
2 - July 6, 2017 - Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy Thu, 06 Jul 2017
-
1 - July 5, 2017 - Diet-Microbiome Interactions in Health Are Controlled by Intestinal Nitrogen Source Constraints Wed, 05 Jul 2017